728O Results from Phase I Dose Escalation of IMC-F106C, the First PRAME × CD3 ImmTAC Bispecific Protein in Solid TumorsO. Hamid,T. Sato,D. Davar,M. K. Callahan,F. Thistlethwaite,R. Aljumaily,M. L. Johnson,H-T. Arkenau,E. E. Ileana Dumbrava,B. Izar,H. A. Chen,S. Marshall, Y. Yuan,M. Deo,S. Stanhope,L. Collins, R. Mundy,S. E. Abdullah,J. S. LopezAnnals of oncology（2022）引用 10|浏览40AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
